In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
FDA approves Xeloda for colorectal cancer
CAMPTOSAR approved for colorectal cancer treatment
IMI agrees license for colorectal cancer diagnostic
Millennium in-licenses novel target for colorectal cancer
Celgene and National Cancer Institute to collaborate on colorectal cancer trial
Merck Applies to Extend Use of Erbitux® for 1st-Line Colorectal Cancer
Epigenomics Licenses Septin 9 Colorectal Cancer Biomarker to Quest Diagnostics
CRT Licenses Colorectal Cancer Risk Technology
Debiopharm extends collaboration with Sanofi-Synthelabo
DIAGNOCURE ACQUIRES EXCLUSIVE WORLDWIDE RIGHTS TO GENE BASED TESTS FOR COLORECTAL CANCER
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
